Publication: 3387

Publication: 3387

A good prognosis of endocrine-dependent tumors among residual invasive cancer after anti-HER2 therapy: CALGB 40601 (Alliance) and validation studies

DOI

URL

Google Scholar

Citation:: Cancer Res vol 81 (4 Supplement) PS10-02

Meeting Instance:: SABCS 2020
Year:: 2020
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: None

Program:: TRP
Primary Committee:: Correl Sci NOS
Sec. Committees:

Pharmas:: GSK
Grants:: U10CA180821, U10CA180882, U24CA196171, U10CA180888, U10CA180818, U10CA180801, P50-CA58223-09A1, R01-CA195740, R01CA229409, P30 CA008748

Corr. Author:
Authors:: Sung Gwe Ahn Aranzazu Fernandez-Martinez Aleix Prat Soong June Bae Núria Chic Fara Brasó-Maristany Benedetta Conte Seho Park Valentina Guarneri Maria Vittoria Dieci Gaia Griguolo PierFranco Conte Joon Jeong Lisa A Carey Charles M. Perou

Networks:: LAPS-NC007

Study: CALGB-40601
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: